Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities

OncLive on Air Powered by PER

Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC

September 30th 2025

Expert Roundtable and Panel Discussions: Current and Future Landscape of TNBC

September 26th 2025

Evaluating the Latest Data and Ongoing Trials for Novel ADC Approaches in TNBC

September 23rd 2025

Establishing the Rationale for ADC and ICI Combinations in TNBC

September 22nd 2025

Dissecting Clinical Trial and Real-World Data for ADCs in TNBC

September 19th 2025

Breaking Down the Rationale for Targeting TROP2 in TNBC

September 16th 2025

Distinguishing Pathway to Precision for c-Met and MET Alterations in NSCLC

August 22nd 2025

42nd Annual Miami Breast Cancer Conference® Podcast: OncLive On Air CE, Powered by PER

June 27th 2025

Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

June 5th 2025
  • Prev
  • 1
  • 2
  • 3
  • Prev

Trending on OncLive

1

Five Under 5: Top Oncology Videos for the Week of 8/31/26

2

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

3

CARiBOU Regimen Drives Complete Metabolic Responses in First-Line Mantle Cell Lymphoma

4

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer

5

Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us